価格表

在庫・価格 : 2024年04月27日 09時06分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
IL-2, Mouse, ELISpot Kit
データシート※最新のデータシートでない場合があります
EL402 RSDアールアンドディー システムス
R&D Systems, Inc.
1 kit ¥80,000
(未発注)
追加

在庫・価格 : 2024年04月27日 09時06分 現在

IL-2, Mouse, ELISpot Kit

  • 商品コード:EL402
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥80,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Takagi Y et al. Anti-tumor effects of dendritic and tumor cell fusions are not dependent on expression of MHC class I and II by dendritic cells. Cancer Lett. 2004 Sep;213(1):49-55
Takagi Y et al
2004/01/01
Sample Type: Whole Cells PubMed
2 Ohmura-Hoshino M et al. Inhibition of MHC class II expression and immune responses by c-MIR. J. Immunol. 2006 Jul;177(1):341-54
Ohmura-Hoshino M et al
2006/01/01
Species: Mouse, Sample type: Whole Cells PubMed
3 Koziczak-Holbro M et al. The critical role of kinase activity of interleukin-1 receptor-associated kinase 4 in animal models of joint inflammation. Arthritis Rheum. 2009 Jun;60(6):1661-71
Koziczak-Holbro M et al
2009/01/01
Sample Type: Whole Cells PubMed
4 Gupta S et al. Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag. J. Virol. 2014 Feb;88(3):1492-501
Gupta S et al
2014/01/01
Sample Type: Whole Cells PubMed
5 Kanagavelu S et al. HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity. PLoS ONE 2014;9(2):e90100
Kanagavelu S et al
2014/01/01
Sample Type: Whole Cells PubMed
6 King TH et al. A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance. PLoS ONE 2014;9(7):e101904
King TH et al
2014/01/01
Sample Type: cell suspensions PubMed
7 Taghinezhad-S S et al. Protection against human papillomavirus type 16-induced tumors in C57BL/6 mice by mucosal vaccination with Lactococcus lactis NZ9000 expressing E6 oncoprotein. Microb. Pathog. 2019 Jan;126:149-156
Taghinezhad-S S et al
2019/01/01
PubMed
8 Mohseni AH et al. Extracellular overproduction of E7 oncoprotein of Iranian human papillomavirus type 16 by genetically engineered Lactococcus lactis. BMC Biotechnol. 2019 01;19(1):8
Mohseni AH et al
2019/01/01
PubMed
  • No.: 1
  • 文献情報:
    Takagi Y et al. Anti-tumor effects of dendritic and tumor cell fusions are not dependent on expression of MHC class I and II by dendritic cells. Cancer Lett. 2004 Sep;213(1):49-55
    Takagi Y et al
    2004/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Ohmura-Hoshino M et al. Inhibition of MHC class II expression and immune responses by c-MIR. J. Immunol. 2006 Jul;177(1):341-54
    Ohmura-Hoshino M et al
    2006/01/01
  • 備考:
    Species: Mouse, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Koziczak-Holbro M et al. The critical role of kinase activity of interleukin-1 receptor-associated kinase 4 in animal models of joint inflammation. Arthritis Rheum. 2009 Jun;60(6):1661-71
    Koziczak-Holbro M et al
    2009/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Gupta S et al. Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag. J. Virol. 2014 Feb;88(3):1492-501
    Gupta S et al
    2014/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Kanagavelu S et al. HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity. PLoS ONE 2014;9(2):e90100
    Kanagavelu S et al
    2014/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    King TH et al. A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance. PLoS ONE 2014;9(7):e101904
    King TH et al
    2014/01/01
  • 備考:
    Sample Type: cell suspensions
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Taghinezhad-S S et al. Protection against human papillomavirus type 16-induced tumors in C57BL/6 mice by mucosal vaccination with Lactococcus lactis NZ9000 expressing E6 oncoprotein. Microb. Pathog. 2019 Jan;126:149-156
    Taghinezhad-S S et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Mohseni AH et al. Extracellular overproduction of E7 oncoprotein of Iranian human papillomavirus type 16 by genetically engineered Lactococcus lactis. BMC Biotechnol. 2019 01;19(1):8
    Mohseni AH et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed